Larasan Pharmaceutical Corporation is a bio-tech company primarily engaged in the development of Over The Counter (OTC), long acting, controlled release, analgesic medications

Larasan specializes in the research and development of OTC pharmaceuticals for manufacturing and distribution into the world-wide marketplace

Larasan has spent over four years to date in product research and development. This research has been effected by both the expertise of its management team together with their highest level contacts. This research was crucial for the development of the Larasan product pipeline. In order to ensure the demographics and logistics confirmed a viable and highly successful opportunity for both Larasan and its shareholders alike.

Larasan is constantly striving to achieve the highest quality, safety, and efficacy of product available in the marketplace, while achieving a better than competitive price to the consumer

Larasan's product pipeline, which is designed for long term growth and high profitability, will insure high return for its shareholder's investments.

Larasan's first product, the 325 mg, controlled release, long lasting aspirin is scheduled for launch during the 1st Quarter, 2008. The two additional dosage strengths are scheduled shortly thereafter, as development will progress simultaneously with this first product development